Vaccine trials on Sudan Ebola strain to start in weeks - WHO chief

Source: Reuters.

The East African country declared an outbreak of Ebola on 20 September and said infections were being caused by the Sudan strain. Uganda's health ministry has confirmed a total of 54 Ebola cases and 19 deaths.

Health minister, Jane Ruth Aceng said the first case was detected in the capital Kampala.

"A sample confirmed that he had Ebola," Aceng told reporters.

A man from central Uganda had travelled to seek treatment at a hospital in the capital, but his condition deteriorated and he died on 7 October. A sample was obtained from his body before burial, which tested positive for Ebola, she said.

There have been worries the spread of infection in Uganda could be difficult to control because currently there is no vaccine for the Sudan strain. The epicentre of the infections is a cluster of five districts in central Uganda.

In a virtual address to a meeting of Africa regional health officials in Kampala, Ghebreyesus said several vaccines were currently being developed that could deal with the Sudan strain.

Two of those vaccines "could be put in clinical trial in Uganda in the coming weeks pending regulatory and other approvals from the Ugandan government," he said.

"Our primary focus now is to rapidly control and contain this outbreak to protect neighbouring districts as well as neighbouring countries."

US to apply Ebola screenings for recent Uganda visitors at 5 airports

David Shepardson  7 Oct 2022

Ghebreyesus did not provide details of the vaccines due for trial such as their names or which firms developed them.

Ebola, a hemorrhagic fever, mainly spreads through contact with the bodily fluids of an infected person. Symptoms of the viral disease include intense weakness, muscle pain, headaches and a sore throat, vomiting, diarrhoea and rashes, among others.

Although it has no vaccine, WHO has previously said the Sudan strain is less transmissible and has shown a lower fatality rate in previous outbreaks than Ebola Zaire.